Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: SignPath Pharma Inc.
November 14, 2025
SignPath Pharma Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of malignant glioma
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
